Molecular Docking Study of Pramipexole Derivatives as Radiopharmaceutical Candidates for Brain Imaging

Molecular Docking Study of Pramipexole Derivatives as Radiopharmaceutical Candidates for Brain Imaging

Neurodegenerative diseases are a global priority disease. According to the World Health Organization (WHO), it is estimated that by 2050, there will be 152 million people with neurodegenerative diseases. Currently, the method used for brain imaging is PET/CT, with the most widely used radiopharmaceu...

Full description

Bibliographic Details
Main Authors: Wibawa Teguh Hafiz Ambar, Rattyananda Badra Sanditya, Setiadi Yanuar, Widyasari Eva Maria, Sriyani Maula Eka, Wongso Hendris, Febrian Muhamad Basit, Mahendra Isa, Kurniawan Ahmad, Halimah Iim, Kusumaningrum Christerra Ellen, Rizaludin Asep, Nuraeni Witri, Mulyati Titin Sri, Rosyidiah Endah
Format: Article
Language:English
Published: EDP Sciences 2024-01-01
Series:E3S Web of Conferences
Online Access:https://www.e3s-conferences.org/articles/e3sconf/pdf/2024/33/e3sconf_isac-iccme2023_03001.pdf

Internet

https://www.e3s-conferences.org/articles/e3sconf/pdf/2024/33/e3sconf_isac-iccme2023_03001.pdf

Similar Items